Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients.

NCT: NCT07673783 · NOT_YET_RECRUITING

NCT IDNCT07673783
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2028-02-29
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS (OTHER)
First posted
Last updated

Brief Summary

The aim of the study is to characterize the neuroinflammatory effects of subthalamic deep brain stimulation in patients with Parkinson's disease, by analyzing changes in blood neuroinflammatory and neurodegenerative biomarkers before and after surgery (at 6 and 12 months, respectively), and comparing the changes in blood biomarkers levels with a control group of patients with advanced PD on best medical treatment.

Frequently Asked Questions

What is Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients.?

Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients. is a clinical trial registered under NCT07673783. Current status: NOT_YET_RECRUITING.

What is the status of NCT07673783?

The current status of NCT07673783 (Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients.) is: NOT_YET_RECRUITING.

When did Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients. start?

Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients. started on 2026-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑